Israel Englander Codiak Bio Sciences, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.18 - $0.81 $24,993 - $112,471	-138,854 Reduced 46.16%	161,957 $28,000
Q4 2022 Feb 14, 2023	SELL	$0.32 - $0.9 $17,011 - $47,844	-53,160 Reduced 15.02%	300,811 $120,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $3.19 $166,132 - $646,294	202,600 Added 133.84%	353,971 $277,000
Q2 2022 Aug 15, 2022	BUY	$2.24 - $6.96 $257,830 - $801,116	115,103 Added 317.37%	151,371 $436,000
Q1 2022 May 16, 2022	BUY	$4.3 - $12.95 $155,952 - $469,670	36,268 New	36,268 $227,000
Q2 2021 Aug 16, 2021	SELL	$11.72 - $26.81 $450,036 - $1.03 Million	-38,399 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.49 - $31.53 $428,914 - $1 Million	31,795 Added 481.45%	38,399 $579,000
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $52,171 - $213,309	6,604 New	6,604 $213,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.